We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$3.11B
AUM Growth
+$443M
Cap. Flow
+$61.7M
Cap. Flow %
1.98%
Top 10 Hldgs %
10.49%
Holding
2,334
New
835
Increased
512
Reduced
385
Closed
526

Sector Composition

Rank Sector Weight
1 Financials 11.99%
2 Healthcare 11.28%
3 Technology 10.89%
4 Communication Services 5.06%
5 Consumer Discretionary 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NG icon
1726
NovaGold Resources
NG
$2.56B
$82K ﹤0.01%
+10,192
New +$96K
LGHLW
1727
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$79K ﹤0.01%
37,800
+1,800
+5% +$497
MFGP
1728
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$78K ﹤0.01%
+10,344
New +$74.2K
MNOV icon
1729
MediciNova
MNOV
$65.5M
$77K ﹤0.01%
+18,051
New +$77.8K
GNSS icon
1730
Genasys
GNSS
$76.1M
$74K ﹤0.01%
+13,486
New +$82.3K
IRD
1731
Opus Genetics
IRD
$306M
$71K ﹤0.01%
13,389
BGMS
1732
Bio Green Med Solution Inc
BGMS
$4.91M
$62K ﹤0.01%
3
-6
-67% -$149K
NYMX
1733
DELISTED
Nymox Pharmaceutical Corp
NYMX
$57K ﹤0.01%
+36,265
New +$67.2K
OTIC
1734
DELISTED
Otonomy, Inc.
OTIC
$54K ﹤0.01%
+24,213
New +$55.9K
GNCA
1735
DELISTED
Genocea Biosciences, Inc.
GNCA
$54K ﹤0.01%
+23,095
New +$55.7K
UBX
1736
DELISTED
Unity Biotechnology
UBX
$46K ﹤0.01%
+1,000
New +$48.2K
MLSS icon
1737
Milestone Scientific
MLSS
$35.3M
$45K ﹤0.01%
+18,293
New +$44.4K
QUAD icon
1738
Quad
QUAD
$536M
$45K ﹤0.01%
+10,751
New +$39K
ENZ
1739
DELISTED
Enzo Biochem, Inc.
ENZ
$44K ﹤0.01%
+13,900
New +$43.7K
CKPT
1740
DELISTED
Checkpoint Therapeutics
CKPT
$43K ﹤0.01%
+1,463
New +$40.5K
ALBT
1741
DELISTED
Avalon GloboCare
ALBT
$41K ﹤0.01%
+278
New +$44.3K
OSG
1742
DELISTED
Overseas Shipholding Group Inc.
OSG
$41K ﹤0.01%
+19,428
New +$43.8K
CBUS icon
1743
Cibus
CBUS
$147M
$40K ﹤0.01%
+201
New +$47.8K
APTO
1744
DELISTED
Aptose Biosciences, Inc.
APTO
$40K ﹤0.01%
27
AGRX
1745
DELISTED
Agile Therapeutics
AGRX
$40K ﹤0.01%
+15
New +$49.5K
CALA
1746
DELISTED
Calithera Biosciences, Inc
CALA
$40K ﹤0.01%
+955
New +$42K
ABEO icon
1747
Abeona Therapeutics
ABEO
$366M
$39K ﹤0.01%
+991
New +$40.4K
GNPX icon
1748
Genprex
GNPX
$3.02M
0
GORO icon
1749
Goldgroup Mining Inc.
GORO
$157M
$39K ﹤0.01%
+14,939
New +$41.4K
TRVG
1750
trivago
TRVG
$373M
$39K ﹤0.01%
+2,340
New +$43.2K

Similar funds

Boothbay Fund Management's Q2 2021 Portfolio in Review

As of Q2 2021, Boothbay Fund Management held 2,334 positions worth $3.11B, up 17% from $2.67B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Boothbay Fund Management's Q2 2021 filing shows 835 new, 512 increased, 385 reduced and 526 closed positions. Its largest new stake was Enthusiast Gaming Holdings Inc. Common Stock: 5,899,688 shares worth $35M. The largest sale was Shopify, an estimated $573M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Technology.

  • Boothbay Fund Management's largest Q2 2021 buy was Enthusiast Gaming Holdings Inc. Common Stock: 5,899,688 shares worth $35M.
  • Boothbay Fund Management added most to Willis Towers Watson in Q2 2021, an estimated $18.4M increase.
  • Boothbay Fund Management's biggest Q2 2021 reduction was Shopify, cutting an estimated $573M.
  • Boothbay Fund Management fully exited Ventoux CCM Acquisition Corp. Unit in Q2 2021, selling an estimated $10.5M.
  • Boothbay Fund Management's ten largest holdings make up 10% of its $3.11B portfolio in Q2 2021.
  • Boothbay Fund Management opened 835 new positions and closed 526 in Q2 2021.
  • Boothbay Fund Management's portfolio value rose 17% quarter-over-quarter to $3.11B.

Based on Boothbay Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.